Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy.
J Cell Biochem
; 119(8): 6598-6603, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-29737543
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
/
Doxorubicin
/
Xenograft Model Antitumor Assays
/
Precision Medicine
/
Temozolomide
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Cell Biochem
Year:
2018
Document type:
Article
Country of publication:
Estados Unidos